The Heart Hospital Baylor Plano in Texas, US, has become the first hospital to integrate two technologies for atrial fibrillation therapy to advance patient care in the arena of cardiac electrophysiology.
The procedure merged multi-electrode mapping (MEM) software, introduced by Biosense Webster, with the Epoch platform.
The Heart Hospital electrophysiology medical director J. Brian DeVille said the procedure is an important step in advancing patient care in the arena of cardiac electrophysiology.
"The integration of these two technologies confirms The Heart Hospital Baylor Plano’s commitment to excellence in patient care and providing advanced treatment to our patients," DeVille said.
"Our goal is always to seek ways to further minimise risk to the patient, which then increases the probability of favourable outcomes."
Leveraging the multi-electrode mapping (MEM) software, the physician handling a MEM-enabled catheter can acquire multiple mapping points at the same time with a higher level of detail, according to hospital officials.
The Epoch platform, an advanced computer-controlled technology, enables physicians to navigate within a patient’s heart with robotic precision.
The Heart Hospital president Mark Valentine said, "We consistently strive to be on the forefront when it comes to innovation because we know that ultimately that is what will serve our patients’ interests in positive ways and help us continue to provide safe, quality, compassionate care."